Ngomhla we-15 kweyoMnga ngo-2025, i-National Medical Products Administration yaseTshayina yavuma ngokusesikweni ukuqaliswa kwemarike yeyeza elitsha lokulwa nomhlaza i-zurletrectinib (ICP-723). Le mpumelelo ibalulekileyo izisa ithemba lonyango elingazange libonwe ngaphambili kwizigulana kwihlabathi liphela ezineethumba eziqinileyo ezine-NTRK fusion genes.
**Unyango oluVuselelweyo lwe-"Tumor-Agnostic": Uphuhliso lweSayensi lweZurletrectinib**
I-Zurletrectinib yi-TRK inhibitor yokuqala yesizukulwana esitsha eTshayina ephuhliswe ngokuzimeleyo, eyenzelwe ngokukodwa izigulane ezinee-tumor eziphucukileyo okanye ezihlala ziqinile eziqulethe ii-Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion genes. Eli yeza "le-tumor-agnostic" elichasene nomhlaza limele utshintsho oluqhelekileyo kwicandelo lonyango lwe-oncology—ukutshintsha ukusuka kudidi lwendabuko olusekelwe kwindawo yemvelaphi ukuya kunyango olujolise ngqo olusekelwe kutshintsho lwemfuza.
**Iimpawu eziphambili:**
* Izigulane ezichongiweyo ngovavanyo oluqinisekisiweyo ngokupheleleyo njengeziphethe i-NTRK fusion gene (ngaphandle kwe-acquired resistance mutations).
* Abantu abadala nabakwishumi elivisayo (abaneminyaka eli-12 nangaphezulu) abaneethumba eziqinileyo ezingenalo unyango olwaneleyo okanye unyango lwangaphambili oluye lwasilela.
**Inzuzo Ephambili:**
Ukuba nje i-NTRK fusion gene ifunyenwe ngovavanyo lwe-genetic, izigulane zinokufumana inzuzo enkulu kunyango lwe-zurletrectinib, nokuba ithumba livela kwimiphunga, kwi-thyroid, emabeleni, kumathumbu amakhulu, okanye kwezinye iindawo.
**Idatha yezonyango ebalaseleyo: Ukuchaza ngokutsha ulindelo lonyango**
Uvavanyo lwezonyango lwe-zurletrectinib olwenziwe eTshayina lubonise idatha ephumelelayo yokusebenza, nto leyo enika ithemba elikhulu lokusinda kwizigulane ezineethumba eziqinileyo eziphucukileyo:
* **Izinga Lokuphendula Lilonke (ORR): 89.1%** — Phantse i-90% yezigulane ziye zancipha kakhulu ithumba.
* **Izinga loLawulo lweSifo (DCR): 96.4%** — Ukuqhubela phambili kwesi sifo kwalawulwa ngempumelelo phantse kuzo zonke izigulana.
* **Izinga lokusinda kweenyanga ezingama-24 ngaphandle kokuqhubela phambili (PFS): 77.4%** — Ulawulo lwexesha elide lokuqhubela phambili kwesifo.
* **Izinga lokusinda lilonke leenyanga ezingama-24 (OS): 90.8%** — Ixesha lokusinda kwesigulana elongezelelekileyo kakhulu.
**ISebe leMicimbi yeHlabathi leSibhedlele se-Oncology saseBeijing South Region: Indlela yakho yoNyango loMhlaza oluPhambili**
ISebe leMicimbi yeHlabathi leSibhedlele i-Oncology saseBeijing South Region lizimisele ukubonelela izigulane zehlabathi ngokufikelela kwizisombululo zonyango lomhlaza eziphucukileyo. Iqela lethu lezonyango lamazwe ngamazwe lizinikele ekuboneleleni ngenkxaso yonyango ebanzi neyobuqu kumntu ngamnye okwilizwe liphela.
Iinkonzo zethu ezikhethekileyo ziquka:
1. Ukubonisana novavanyo lonyango lwezigulane lwamazwe ngamazwe.
2. Ulungiselelo kunye nokutolikwa kovavanyo lwe-NTRK fusion gene.
3. Ukubonisana neengcali ezininzi kunye nocwangciso olupheleleyo lonyango.
4. Inkxaso yoguqulelo lwezonyango olusebenzisa iilwimi ezininzi kunye nohlengahlengiso lwenkcubeko.
**Nxibelelana neSebe leMicimbi yeHlabathi leSibhedlele se-Oncology saseBeijing South Region**
Siyaziqonda iingxaki kunye nemingeni abaguli bamanye amazwe abajongene nayo xa befuna unyango kwamanye amazwe. Ke ngoko, simisele iindlela zonxibelelwano ezilula nezihlukeneyo ukuqinisekisa ukuba unokufikelela lula kulwazi lwezonyango olusemthethweni kwaye uqalise inkqubo yonyango.
**Indlela yoQhagamshelwano ekhethwayo:**
* Inombolo yomnxeba yezigulane zamazwe ngamazwe: 400-880-3716
**Iindlela ezahlukeneyo zoQhagamshelwano:**
* Ingxoxo yeWeChat: Yongeza i-ID ethi “17801183037″ ukuze ufumane ingcebiso esekelwe kwimiyalezo kunye neempendulo ezikhawulezayo.
* Ukubonisana nge-imeyile:
* General Inquiry: 100085_010@163.com
* International Medical Exclusive: myimmnet@163.com
**Inkqubo Yesigulana Samazwe Ngamazwe:**
1. Nxibelelana noMququzeleli wethu weZigulana zaMazwe ngaMazwe ngokusebenzisa nayiphi na indlela kwezi zingentla.
2. Ngenisa iirekhodi zonyango ukuze zihlolwe kwangaphambili (kuquka iingxelo zesifo, iziphumo zovavanyo lwemfuza, njl.njl.).
3. Cwangcisa ukubonisana ngevidiyo kude nengcali ye-oncology yehlabathi.
4. Ukuba unyango eTshayina luyadingeka, siza kunceda ngokulungiswa kwe-visa yezonyango, amalungiselelo okuhlala, kunye nezinye izinto ezifunekayo.
5. Yonwabela iinkonzo zonyango ezifika kanye xa ufika eBeijing, ukusuka ekuthathweni kwisikhululo seenqwelo-moya ukuya kulo lonke uhambo lonyango.
**Isikhumbuzo Esibalulekileyo: Uvavanyo Lwemfuza Ngaphambi Konyango Lubalulekile**
Njengeyeza elijoliswe kulo, ukusebenza kakuhle kwe-zurletrectinib kuxhomekeke kakhulu kuvavanyo oluchanekileyo lwe-genetic. Sicebisa ukuba zonke izigulana ezicinga ngolu nyango ziqale zenze uvavanyo lwe-NTRK fusion gene. ISebe le-Beijing South Region Oncology Hospital International linokukulungiselela iinkonzo zovavanyo ezaziwayo kwihlabathi liphela okanye likubonelele ngengcaciso egunyazisiweyo yeziphumo zakho zovavanyo ezikhoyo.
**Ukujonga Phambili: Ixesha Elitsha Lonyango Lomhlaza Olulungiselelwe Wena**
Ukuvunywa kwe-zurletrectinib akupheleli nje ekuqalisweni kweyeza elitsha; bubungqina obunamandla bezakhono zaseTshayina kunyango lomhlaza oluchanekileyo. ISebe leMicimbi yeHlabathi leSibhedlele i-Oncology saseBeijing South Region liza kuqhubeka nokulandela inkqubela phambili yehlabathi kunyango lomhlaza, lidibanise izixhobo zonyango ezikumgangatho ophezulu ezivela kwimithombo yasekhaya neyamazwe ngamazwe, kwaye libonelele ngeenkonzo zokuxilonga umhlaza kunye nonyango olujoliswe kwisigulana kwihlabathi liphela kwizigulane zamazwe ngamazwe.
**Fowunela ngoku ukuze ubuze ukuba wena okanye umntu omthandayo ungumntu oza kungena kweli candelo lonyango litsha!**
Inombolo yomnxeba yezigulane zamazwe ngamazwe kwiSibhedlele saseBeijing South Region Oncology International Department: 400-880-3716
I-ID ye-WeChat: 17801183037
Email: 100085_010@163.com; myimmnet@163.com
**Qaphela:** Ulwazi lwezonyango olukweli nqaku lusekelwe kwidatha yovavanyo lwezonyango olufumaneka esidlangalaleni. Izicwangciso zonyango ezithile kufuneka zenziwe ngoogqirha abaziingcali ngokusekelwe kwiimeko zesigulana ngasinye. Kucetyiswa ukuba zonke izigulana zibonane neengcali zempilo ezifanelekileyo ngaphambi kokuba zicinge ngalo naluphi na unyango.
Ixesha leposi: Disemba-31-2025